Cargando…
Aberrant expression of N-glycolyl GM3 ganglioside is associated with the aggressive biological behavior of human sarcomas
BACKGROUND: The aberrant expression of N-glycolyl GM3 ganglioside (NeuGcGM3) in patients with sarcomas was reevaluated by assessing the relation of this molecule with some clinicopathological features and overall survival (OS) of patients. METHODS: Fifty formalin-fixed and paraffin-embedded specimen...
Autores principales: | Pilco-Janeta, Daniel, De la Cruz Puebla, Myriam, Soriano, Jorge, Osorio, Marta, Caballero, Iraida, Pérez, Adanays Calvo, Savon, Laynes, Cremades, Natalia, Blanco, Rancés, Carr, Adriana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558727/ https://www.ncbi.nlm.nih.gov/pubmed/31182063 http://dx.doi.org/10.1186/s12885-019-5743-9 |
Ejemplares similares
-
Prognostic Role of 14F7 Mab Immunoreactivity against N-Glycolyl GM3 Ganglioside in Colon Cancer
por: Lahera, Tania, et al.
Publicado: (2014) -
Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences
por: Blanco, Rancés, et al.
Publicado: (2015) -
Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Primary Lymphoid Tumors and Lymph Node Metastasis
por: Blanco, Rancés, et al.
Publicado: (2013) -
Immunoreactivity of the 14F7 Mab Raised against N-Glycolyl GM3 Ganglioside in Epithelial Malignant Tumors from Digestive System
por: Blanco, Rancés, et al.
Publicado: (2011) -
Immunohistochemical Reactivity of the 14F7 Monoclonal Antibody Raised against N-Glycolyl GM3 Ganglioside in Some Benign and Malignant Skin Neoplasms
por: Blanco, Rancés, et al.
Publicado: (2011)